C-MER Medical Declares HKD 0.02 Final Dividend for FY2025

C-MER Eye Care Holdings Limited ( (HK:3309) ) has provided an update.

C-MER Medical Holdings Limited has declared a final ordinary cash dividend of HKD 0.02 per share for the financial year ended 31 December 2025, subject to shareholder approval at a meeting scheduled for 20 May 2026. The dividend will be paid in Hong Kong dollars, with shares trading ex-dividend on 29 June 2026, a record date of 6 July 2026, and payment to eligible shareholders on 15 July 2026.

The announcement underscores the company’s intention to return cash to shareholders, signaling confidence in its financial performance and balance sheet as of the 2025 year-end. The detailed timetable for book closure and registration ensures clarity for investors on eligibility, while the absence of withholding tax and other complex instruments simplifies the distribution framework for stakeholders.

The most recent analyst rating on (HK:3309) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on C-MER Eye Care Holdings Limited stock, see the HK:3309 Stock Forecast page.

More about C-MER Eye Care Holdings Limited

C-MER Medical Holdings Limited operates in the healthcare sector, focusing on medical and eye care services in Hong Kong and potentially broader Asian markets. The company is listed on the Main Board of the Hong Kong Stock Exchange under stock code 3309 and is overseen by a board comprising executive and independent non-executive directors.

Average Trading Volume: 454,086

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.54B

See more data about 3309 stock on TipRanks’ Stock Analysis page.